Psoriasis: Prevalence, Clinical Variants and Quality of Life, Among Patients Attending the Skin Clinic at Mbarara Regional Referral Hospital, Uganda [0.03%]
乌干达姆巴拉拉地区转诊医院皮肤科患者的银屑病患病率、临床亚型和生活质量研究
Hayidar Lubwama,Grace Kitunzi Mulyowa,Stephen Kizito Mirembe et al.
Hayidar Lubwama et al.
Introduction: Psoriasis is a chronic, relapsing inflammatory skin disorder that causes a detrimental physical and psychological impact on people living with the disease. However, little is known about its current prevalen...
Analysis of the Reduction in the Duration of Sick Leave for 32,512 Psoriasis Patients Following the Integration of Targeted Therapies for Psoriatic Disease into the Brazilian Healthcare System: a Retrospective Cohort Study [0.03%]
巴西纳入生物制剂治疗后银屑病患者的疾病休工时长变化：一项基于回顾性队列的研究分析
Luiza Ferreira Vieira D&#x;Almeida,Gleison Vieira Duarte,Marcos Paulo Godinho et al.
Luiza Ferreira Vieira D&#x;Almeida et al.
Purpose: The Brazilian Unified Health System is an interesting model for international healthcare innovation analysis. Covering over 200 million people, this system stands out as one of the largest purchasers of healthcar...
Treatment With Schistosoma Japonicum Peptide SJMHE1 and SJMHE1-Loaded Hydrogel for the Mitigation of Psoriasis [0.03%]
施用日本血吸虫肽SJMHE1以及负载SJMHE1的水凝胶以缓解银屑病严重程度的研究
Xi Liu,Shang Wang,Yuyun Jiang et al.
Xi Liu et al.
Purpose: Harnessing helminth-induced immunomodulation offers a novel therapeutic avenue for autoimmune and inflammatory diseases; however, research on helminths against psoriasis remains limited. This study evaluates the ...
Treatment of Psoriasis with II-17 Inhibitors: Comparison of Long-Term Effectiveness and Drug Survival of Secukinumab vs Ixekizumab in Real-World Practice [0.03%]
II-17抑制剂治疗银屑病：真实世界实践中塞库单抗与伊克西珠单抗的长期有效性和药物生存期比较
Joan Lam,Simone Cazzaniga,S Morteza Seyed Jafari et al.
Joan Lam et al.
Introduction: The emergence of IL-17A inhibitors, has led to improvements in psoriasis treatment. However, comparative studies addressing their long-term efficacy and drug survival with associated predictors are scarce. T...
Acrodermatitis Continua of Hallopeau and Generalised Pustular Psoriasis: Case Reports of Two Different Manifestations of IL36RN Mutation in Siblings [0.03%]
Hallopeau连续性痤疮样皮炎和泛发性脓疱型银屑病：拥有IL36RN突变的兄弟姐妹的不同表现形式的病例报告
Mengjiao Gu,Hanjing Huang,Zhanshuo Xiao et al.
Mengjiao Gu et al.
In our manuscript, we present a case study of siblings with Generalized Pustular Psoriasis (GPP) and Acrodermatitis Continua of Hallopeau (ACH), both harboring IL36RN gene mutations. The 3-year-old proband exhibited systemic pustules leadin...
A Randomized Controlled Trial for the Optimal Implementation of Psoriasis Treatment by Integrating Chinese and Western Medicine [0.03%]
中西医结合治疗银屑病的最优实施方案的随机对照试验
Yuanting Yu,Xiaoying Sun,Rongyi Hu et al.
Yuanting Yu et al.
Background: Psoriasis is a refractory inflammatory disease affecting people worldwide. Currently, the prevalent guideline-recommended regimen is based on psoriasis severity; however, no corresponding studies have been con...
Clinical Trial
Psoriasis (Auckland, N.Z.). 2025 Mar 21:15:55-66. DOI:10.2147/PTT.S487536 2025
Metagenomics Analysis of Altered Gut Microbiome in Psoriasis and the Mediation Analysis: A Case-Control Study [0.03%]
银屑病中改变的肠道微生物组的宏基因组学分析和介导分析：一项病例对照研究
Yi Xiao,Danrong Jing,Hui Xiao et al.
Yi Xiao et al.
Purpose: Psoriasis is an inflammatory disease linked to gut microbiome dysbiosis. However, the mechanisms underlying gut microbiome changes caused by dietary habits in psoriasis remain unclear. ...
Baseline Pathological Liver Function Tests in Patients With Psoriasis Support the Indication for Systemic Therapy Rather Than Being a Reason Against It: A Real-World Analysis [0.03%]
银屑病患者的基本病理肝功能检测是支持系统治疗的指征而非相反的证据：现实世界分析
Frederik Krefting,Cosima Scheib,Sven Benson et al.
Frederik Krefting et al.
Purpose: Modern systemic therapies offer a high probability of significant improvement for psoriasis. However, elevated liver function tests (LFTs) may cause physicians to be reluctant to initiate systemic treatment. Espe...
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report [0.03%]
依奇珠单抗治疗线性银屑病一例报告
Slatina Christov,Frenz Ohm,Matthias Augustin et al.
Slatina Christov et al.
Linear psoriasis (LP) represents a rare variant of psoriasis. The clinical presentation includes erythematous plaques distributed along the Blaschko lines, reflecting the presence of embryological mosaicism. The clinical and histopathologic...
Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients [0.03%]
调整银屑病患者对secukinumab的治疗预期以优化疗效
Stefanie Hölsken,Frederik Krefting,Senta Mühlhaus et al.
Stefanie Hölsken et al.
Purpose: Patients' treatment expectations significantly influence the effectiveness of medical and pharmacological treatments. This clinical proof-of-concept study aimed to enhance treatment outcomes by targeting positive...
Clinical Trial
Psoriasis (Auckland, N.Z.). 2025 Jan 10:15:9-22. DOI:10.2147/PTT.S486338 2025